Incidence and Typical Prognosis of HER2+ Early Breast Cancer


Virginia Borges, MD, explains how common HER2+ early breast cancer is and the goals of treatment for patients.

Related Videos
A panel of 5 experts on renal cell carcinoma
Chandler H. Park, MD, an expert on renal cell carcinoma
Video 8 - "Post-Thyroidectomy Management: Thyroid Hormone Replacement and TSH Suppression"
Video 7 - "The Importance of Thyroidectomy in DTC Patient Care"
Ko Un “Clara” Park, MD
Erin Frances Cobain, MD
A panel of 6 experts on colorectal cancer
A panel of 6 experts on colorectal cancer
Video 3 - "5-Year Data from the MonarchE Trial Investigating Abemaciclib in HR+, HER2- High-Risk, Early Breast Cancer"
A panel of 4 experts on colorectal cancer